[ad_1]
Highlights
- “Highly likely” its vaccine works towards mutated pressure, BioNTech stated
- Could present a brand new vaccine in six weeks, co-founder stated
- Mutated pressure first reported in Britain
Berlin:
The co-founder of BioNTech stated Tuesday it was “highly likely” that its vaccine towards the coronavirus works towards the mutated pressure detected in Britain, nevertheless it might additionally adapt the vaccine if essential in six weeks.
“Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant,” stated Ugur Sahin.
But if wanted, “in principle the beauty of the messenger technology is that we can directly start to engineer a vaccine which completely mimics this new mutation — we could be able to provide a new vaccine technically within six weeks.”
(Except for the headline, this story has not been edited by NDTV workers and is revealed from a syndicated feed.)
[ad_2]
Source hyperlink